The Safety and Efficacy of Intravenous Enalaprilat In Acute Cardiogenic Pulmonary Edema [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 1998; 26(4): 234-238

The Safety and Efficacy of Intravenous Enalaprilat In Acute Cardiogenic Pulmonary Edema

Kani GEMİCİ1, İbrahim BARAN1, Dilek YEŞİLBURSA1, Sümeyye GÜLLÜLÜ1, Bülent İLÇÖL1, Ali AYDINLAR1, Ali Rıza KAZAZOĞLU1, Akın SERDAR1, Ethem KUMBAY1, Jale CORDAN1

Angiotensin-converting enzyme (ACE) inhibitors which have been used for the treatment of chronic congestive heart failure, can also be used for the treatment of acute cardiogenic pulmonary edema. In this condition, patients are hemodynamically unstable and have high renin levels. The studies in this area are limited. The purpose of this study was to evaluate the efficacy and safety of intravenous enalaprilat in patients with acute cardiogenic pulmonary edema. The study was performed in 12 patients (7 men, 5 women; mean age 57.2±7.4 years) with acute cardiogenic pulmonary edema due to dilated cardiomyopathy, coronary artery disease, hypertensive heart disease or coronary and/or hypertensive heart disease. Hemodynamic and elinical parameters were measured and evaluated before and 1 O minutes after infusion of enalaprilat. Enalaprilat increased cardiac output, cardiac index and stroke volume (pKeywords: Acute cardiogenic pulmonary edema, enalaprilat, hemodynamic effects.


How to cite this article
Kani GEMİCİ, İbrahim BARAN, Dilek YEŞİLBURSA, Sümeyye GÜLLÜLÜ, Bülent İLÇÖL, Ali AYDINLAR, Ali Rıza KAZAZOĞLU, Akın SERDAR, Ethem KUMBAY, Jale CORDAN. The Safety and Efficacy of Intravenous Enalaprilat In Acute Cardiogenic Pulmonary Edema. Turk Kardiyol Dern Ars. 1998; 26(4): 234-238
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale